Olmesartan Medoxomil Tablets 5mg

Olmesartan Medoxomil Tablets 5mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Olmesartan Medoxomil Tablets USP 5mg
2. Olmesartan Medoxomil Tablets USP 20mg
3. Olmesartan Medoxomil Tablets USP 40mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Olmesartan Medoxomil Tablets USP 5mg
Each film-coated tablet contains:
Olmesartan Medoxomil USP……………5mg
Excipients……………………………………….q.s
Color: Sunset yellow FCF

2.Olmesartan Medoxomil Tablets USP 20mg
Each film-coated tablet contains:
Olmesartan Medoxomil USP……………20mg
Excipients……………………………………….q.s
Color: Ponceau 4R

3. Olmesartan Medoxomil Tablets USP 40mg
Each film-coated tablet contains:
Olmesartan Medoxomil USP……………40mg
Excipients……………………………………….q.s
Color: Ponceau 2R

THERAPEUTIC INDICATIONS:

Olmesartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Dispense in a tight, light-resistant container as defines in the USP using a child-resistant closure.
Keep container tightly closed.

Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

When pregnancy is detected, Olmesartan should be discontinued as soon as possible, as it can cause injury and even death to the developing fetus, when used during the second and third trimester of pregnancy.

STORAGE & DOSAGE:

Storage: Store at 20° to 25°C (68° to 77°F)
Store in dry place protected from light and moisture.

Dosage: As directed by the Physician

Attach dispensing label as per end country.

1. An Introduction to Olmesartan Medoxomil Tablets 5mg: Precision Dosing for Specialized Hypertension Management

Olmesartan Medoxomil Tablets 5mg represents a significant advancement in personalized hypertension treatment, offering clinicians a sophisticated tool for managing blood pressure in specific patient populations where standard dosing may be excessive or poorly tolerated. This ultra-low dose formulation demonstrates the pharmaceutical industry’s evolution toward more precise, patient-centric treatment approaches.

• Advanced Mechanism of Action: Olmesartan Medoxomil functions as a prodrug that undergoes rapid enzymatic conversion to its active form, olmesartan, during gastrointestinal absorption. It operates through highly selective blockade of angiotensin II AT1 receptors, effectively inhibiting the potent vasoconstrictive effects of the renin-angiotensin-aldosterone system while maintaining the potential beneficial effects of angiotensin II acting on AT2 receptors. 🩺

• Strategic Clinical Applications: The 5mg strength serves critical therapeutic roles in:

  • Initial therapy for patients with mild hypertension or high-normal blood pressure

  • Treatment initiation in elderly patients with age-related pharmacokinetic changes

  • Management of hypertension in patients with moderate to severe renal impairment

  • Dose titration in combination therapy protocols requiring minimal olmesartan contribution

  • Long-term maintenance therapy for patients responsive to ultra-low dosing

The global demand for Olmesartan Medoxomil 5mg continues to grow steadily, driven by aging populations, increased prevalence of renal comorbidities in hypertensive patients, and heightened physician awareness of the importance of gentle treatment initiation. As a leading Olmesartan Medoxomil Tablets 5mg supplier, Taj Pharma addresses this sophisticated market need with precision-engineered formulations that ensure consistent therapeutic performance at this challenging low dosage strength.

2. In-Depth Details for Importers, Exporters, and Bulk Buyers

Taj Pharma has established comprehensive export protocols specifically designed to facilitate seamless international procurement of specialized low-dose formulations, with particular emphasis on regulatory compliance and quality assurance.

📄 Comprehensive Regulatory Documentation & Export Certifications

We maintain meticulous documentation standards to support our global partners’ regulatory requirements:

• Certificate of Analysis (COA): Batch-specific documentation with enhanced testing parameters for low-dose formulation uniformity, confirming identity, potency, purity, and dissolution profile according to stringent pharmacopeial standards

• Certificate of Pharmaceutical Product (CPP): WHO-formatted certificate specifically validating the 5mg strength for international product registration

• CTD Dossier: Meticulously prepared Common Technical Document with specialized sections addressing low-dose formulation characteristics and bioequivalence data

• Stability Studies Data: Comprehensive accelerated and real-time stability data proving product integrity under ICH-guided storage conditions

Our specialized manufacturing facility in Vapi, Gujarat, maintains the highest international certifications with particular expertise in low-dose formulations:

• WHO-GMP (World Health Organization – Good Manufacturing Practice) ✅

• EU-GMP (European Union Good Manufacturing Practice) ✅

• ISO 9001:2015 Certification ✅

📦 Custom Packaging & Labeling

Recognizing the specialized nature of ultra-low dose medications, we offer tailored packaging solutions:

• Blister Packs: Standard 10-tablet strips with enhanced color differentiation and clear strength identification using pharmaceutical-grade Alu-Alu packaging

• Bottle Packaging: Secure HDPE bottles with specialized desiccant systems and tamper-evident seals for bulk institutional orders

• Labeling: Fully compliant with destination country regulations with prominent strength display, multi-language options, and comprehensive private labeling services

🧪 Shelf-Life, Storage, and Dosage Form

• Dosage Form: Film-coated tablet with specialized excipient blend for optimal low-dose content uniformity

• Standard Shelf-Life: 36 months from manufacturing date when stored under recommended conditions

• Storage Conditions: Store below 30°C in a dry place, protected from light and moisture, with enhanced stability monitoring

🎯 Target Export Markets & Countries

Taj Pharma exports Olmesartan Medoxomil Tablets 5mg to over 65 countries worldwide, with specialized regulatory expertise in:

• African Markets: Nigeria, South Africa, Kenya, Uganda, Tanzania, Ghana

• Southeast Asia: Philippines, Vietnam, Malaysia, Myanmar, Indonesia

• Middle East: Saudi Arabia, UAE, Yemen, Oman, Kuwait

• Latin America: Brazil, Mexico, Colombia, Chile, Peru

• European Markets: Ukraine, Kazakhstan, Georgia, Azerbaijan

3. Why Taj Pharma is the Most Trusted Manufacturer, Supplier, and Exporter

🏭 Advanced Manufacturing Technology for Low-Dose Formulations

Taj Pharma’s manufacturing facility incorporates specialized technology specifically designed for precision low-dose production. Our dedicated manufacturing suite for Olmesartan Medoxomil Tablets 5mg features:

• High-Shear Mixing Technology: Ensures absolute homogeneity of active ingredient distribution in the powder blend

• Micro-dosing Compression Equipment: Guarantees tablet weight and content uniformity with minimal variance

• In-line Monitoring Systems: Real-time quality control during compression and coating processes

• Enhanced Cleaning Validation: Prevents cross-contamination in low-dose manufacturing environments

Our production strictly adheres to WHO-GMP and EU-GMP guidelines, with each batch undergoing enhanced quality testing including content uniformity analysis, dissolution profiling, and accelerated stability studies to ensure consistent therapeutic performance at this challenging dosage strength. ✅

💰 Competitive Pricing Through Manufacturing Excellence

Our specialized manufacturing approach for low-dose formulations incorporates efficiency measures that enable competitive international pricing without compromising quality. Through optimized raw material utilization, streamlined production processes, and vertical integration, we deliver exceptional value while maintaining the highest quality standards expected from a WHO-GMP manufacturer in India.

🌍 Global Supply Chain Excellence

Taj Pharma has developed a sophisticated global distribution network with particular expertise in handling specialized cardiovascular medications. Our supply chain capabilities include:

• Temperature-Controlled Shipping: For sensitive markets with extreme climate conditions

• Regulatory Intelligence: Updated knowledge of import requirements across target markets

• Strategic Stocking: Regional inventory management to ensure supply continuity

• Documentation Expertise: Efficient handling of complex import documentation requirements

🗺️ Top 20 Countries We Export To

USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia

4. Technical Product Specification Table

5.  Partner with India’s Leading Low-Dose Cardiovascular Specialist

Whether you are a global distributor, government health agency, hospital procurement network, or exploring PCD Pharma Franchise opportunities, Taj Pharma offers specialized expertise in low-dose cardiovascular medications.

Secure your supply of precision-dose antihypertensive medication from India’s most trusted low-dose manufacturer. Contact Taj Pharma today for competitive quotes, samples, and partnership discussions.

📧 Email:  info@tajpharma.com
🌐 Website: https://www.tajpharma.com
📞 Phone: +9122-2634 1274

6. Top 20 FAQs  

Q1. What is the primary indication for Olmesartan Medoxomil 5mg?
A1. It is primarily used for treatment of mild hypertension, initial therapy in sensitive patients, and for patients with renal impairment requiring lower dosing.

Q2. How does the 5mg strength compare to higher strengths?
A2. The 5mg strength provides approximately 50% of the angiotensin receptor blockade of the 10mg dose, making it ideal for gentle treatment initiation or maintenance in sensitive patients.

Q3. What are the most common side effects at this low dose?
A3. Side effects are generally mild and may include dizziness, headache, or fatigue, though incidence rates are typically lower than with higher doses.

Q4. Can Taj Pharma provide a Certificate of Analysis for the 5mg strength?
A4. Yes, we provide enhanced COAs with additional content uniformity data specifically for our low-dose formulations.

Q5. Do you offer specialized packaging for low-dose medications?
A5. Absolutely. We provide distinctive packaging with clear strength identification to prevent medication errors, along with comprehensive private labeling options.

Q6. What is your minimum order quantity for the 5mg strength?
A6. We offer flexible MOQs recognizing the specialized nature of this dosage strength. Contact our export team for specific requirements.

Q7. Are you certified for low-dose manufacturing?
A7. Yes, our WHO-GMP certification specifically covers our low-dose manufacturing capabilities with enhanced quality controls.

Q8. What is the shelf life of your Olmesartan 5mg tablets?
A8. Our tablets have a 36-month shelf life when stored under recommended conditions.

Q9. Which patient populations are best suited for the 5mg strength?
A9. This strength is ideal for elderly patients, those with renal impairment, patients with mild hypertension, and anyone requiring gentle dose initiation.

Q10. Do you offer PCD Pharma Franchise for the 5mg strength?
A10. Yes, we offer exclusive PCD Pharma Franchise opportunities for Olmesartan Medoxomil Tablets 5mg across various Indian territories.

Q11. Is dose titration possible from the 5mg strength?
A11. Yes, the 5mg strength provides an excellent foundation for careful dose titration based on individual patient response.

Q12. How does food affect absorption of the 5mg dose?
A12. Food may slightly delay absorption but does not significantly affect overall bioavailability, allowing flexible administration timing.

Q13. Can you supply clinical trial quantities of the 5mg strength?
A13. Yes, we have experience supplying specialized dosage strengths for clinical research purposes with complete documentation support.

Q14. What documentation do you provide for the 5mg formulation?
A14. We provide complete regulatory documentation including formulation-specific data, enhanced stability information, and bioequivalence references.

Q15. What is your production capacity for the 5mg strength?
A15. We maintain dedicated production lines with significant capacity to ensure reliable supply of this specialized strength.

Q16. Is this medication suitable for patients with diabetes?
A16. Yes, Olmesartan is often preferred in diabetic patients due to its neutral metabolic profile and renal protective potential.

Q17. Can we request bioequivalence data for the 5mg formulation?
A17. Yes, we can provide relevant bioequivalence data to support regulatory submissions in your target markets.

Q18. What excipient system do you use for content uniformity?
A18. We employ a specialized excipient blend and manufacturing process specifically designed to ensure perfect content uniformity in our low-dose formulations.

Q19. How does Taj Pharma ensure consistency in low-dose manufacturing?
A19. Through specialized equipment, enhanced process controls, and rigorous quality testing that exceeds standard pharmacopeial requirements for low-dose products.

Q20. Why should we choose Taj Pharma for the 5mg strength?
A20. Taj Pharma combines specialized low-dose manufacturing expertise, WHO-GMP certified quality, competitive pricing, and extensive global experience, making us the ideal partner for this sophisticated dosage strength.